Genetic variation in IL28B is associated with response to the therapy for chronic hepatitis C

被引：0
|
作者：
Sugiyama, Masaya [1 ,2 ]
Tanaka, Yasuhito [2 ]
机构：
[1] Nagoya City Univ, Sch Med, Dept Biochem & Cell Biol, Mizuho Ku, Nagoya, Aichi 4670001, Japan
[2] Nagoya City Univ, Sch Med, Dept Virol, Mizuho Ku, Nagoya, Aichi 4670001, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2010年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：27P / 27P
页数：1
相关论文
共 50 条
  • [1] HEPATIC ISGS ARE ASSOCIATED WITH GENETIC VARIATION IN IL28B AND THE OUTCOME OF IFN THERAPY FOR CHRONIC HEPATITIS C
    Honda, Masao
    Sakai, Akito
    Yamashita, Tatsuya
    Nakamoto, Yasunari
    Mizukoshi, Eishiro
    Sakai, Yoshio
    Yamashita, Taro
    Nakamura, Mikiko
    Shirasaki, Takayoshi
    Horimoto, Katsuhisa
    Tanaka, Yasuhito
    Tokunaga, Katsushi
    Mizokami, Masashi
    Kaneko, Shuichi
    HEPATOLOGY, 2010, 52 (04) : 730A - 730A
  • [2] Genetic Variation in IL-28B Is Associated With Response to the Therapy for Chronic Hepatitis C
    Sugiyama, Masaya
    Tanaka, Yasuhito
    Nakanishi, Makoto
    Mizokami, Masashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 (03) : 263 - 269
  • [3] Genetic variation in IL28B and hepatitis C outcomes
    Muir, Andrew J.
    CYTOKINE, 2010, 52 (1-2) : 49 - 49
  • [4] IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients
    Venegas, Mauricio
    Villanueva, Rodrigo A.
    Gonzalez, Katherine
    Brahm, Javier
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (31) : 3636 - 3639
  • [5] IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
    Vijayaprakash Suppiah
    Max Moldovan
    Golo Ahlenstiel
    Thomas Berg
    Martin Weltman
    Maria Lorena Abate
    Margaret Bassendine
    Ulrich Spengler
    Gregory J Dore
    Elizabeth Powell
    Stephen Riordan
    David Sheridan
    Antonina Smedile
    Vincenzo Fragomeli
    Tobias Müller
    Melanie Bahlo
    Graeme J Stewart
    David R Booth
    Jacob George
    Nature Genetics, 2009, 41 : 1100 - 1104
  • [6] IL28B GENOTYPING FOR 2 SNPS ASSOCIATED WITH CHRONIC HEPATITIS C THERAPY RESPONSE
    Rosso, C.
    Abate, M. L.
    Ciancio, A.
    Smedile, A.
    Rizzetto, M.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S529 - S529
  • [7] IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
    Suppiah, Vijayaprakash
    Moldovan, Max
    Ahlenstiel, Golo
    Berg, Thomas
    Weltman, Martin
    Abate, Maria Lorena
    Bassendine, Margaret
    Spengler, Ulrich
    Dore, Gregory J.
    Powell, Elizabeth
    Riordan, Stephen
    Sheridan, David
    Smedile, Antonina
    Fragomeli, Vincenzo
    Mueller, Tobias
    Bahlo, Melanie
    Stewart, Graeme J.
    Booth, David R.
    George, Jacob
    NATURE GENETICS, 2009, 41 (10) : 1100 - U74
  • [8] IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients
    Mauricio Venegas
    Rodrigo A Villanueva
    Katherine González
    Javier Brahm
    World Journal of Gastroenterology, 2011, 17 (31) : 3636 - 3639
  • [9] Genetic Variation in IL28B: Impact on Drug Development for Chronic Hepatitis C Infection
    Clark, P. J.
    Thompson, A. J. V.
    McHutchison, J. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (05) : 708 - 711
  • [10] IL28B GENETIC VARIANTS ARE NOT ASSOCIATED WITH SERUM IL28B LEVELS IN ADULTS WITH CHRONIC HEPATITIS C. PILOT STUDY
    Bialkowska, J.
    Szemraj, J.
    Jablkowski, M.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S321 - S321
12345